CA2102890A1 - Derives n-carboxyalkylpeptidyles substitues utilises comme agents antidegeneratifs - Google Patents
Derives n-carboxyalkylpeptidyles substitues utilises comme agents antidegeneratifsInfo
- Publication number
- CA2102890A1 CA2102890A1 CA002102890A CA2102890A CA2102890A1 CA 2102890 A1 CA2102890 A1 CA 2102890A1 CA 002102890 A CA002102890 A CA 002102890A CA 2102890 A CA2102890 A CA 2102890A CA 2102890 A1 CA2102890 A1 CA 2102890A1
- Authority
- CA
- Canada
- Prior art keywords
- ethyl
- carboxy
- glycine
- phenyl
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70582691A | 1991-05-28 | 1991-05-28 | |
US705,826 | 1991-05-28 | ||
US87390592A | 1992-04-24 | 1992-04-24 | |
US873,905 | 1992-04-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2102890A1 true CA2102890A1 (fr) | 1992-11-29 |
Family
ID=27107579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002102890A Abandoned CA2102890A1 (fr) | 1991-05-28 | 1992-05-01 | Derives n-carboxyalkylpeptidyles substitues utilises comme agents antidegeneratifs |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0586537A4 (fr) |
JP (1) | JPH06508135A (fr) |
CA (1) | CA2102890A1 (fr) |
WO (1) | WO1992021360A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
US5773428A (en) * | 1993-08-05 | 1998-06-30 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
US6013792A (en) * | 1993-08-05 | 2000-01-11 | Syntex (U.S.A.), Inc. | Matrix metalloprotease inhibitors |
HU222818B1 (hu) * | 1993-08-05 | 2003-11-28 | Syntex (U.S.A.) Inc. | Mátrix metalloproteáz inhibitor hatású indolszármazékok, előállításuk és a vegyületeket tartalmazó gyógyászati készítmények |
US5470834A (en) * | 1993-10-06 | 1995-11-28 | Florida State University | Sulfoximine and suldodiimine matrix metalloproteinase inhibitors |
US5455262A (en) * | 1993-10-06 | 1995-10-03 | Florida State University | Mercaptosulfide metalloproteinase inhibitors |
US5403952A (en) * | 1993-10-08 | 1995-04-04 | Merck & Co., Inc. | Substituted cyclic derivatives as novel antidegenerative agents |
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
DE69502378T2 (de) * | 1994-01-20 | 1998-10-01 | British Biotech Pharm | Metalloproteinaseinhibitoren |
AU2361295A (en) * | 1994-04-28 | 1995-11-29 | Merck & Co., Inc. | N-carboxyalkyl derivatives as antidegenerative active agents |
US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
WO1996033733A1 (fr) * | 1995-04-25 | 1996-10-31 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Nouveau remede pour affections cutanees |
US6281352B1 (en) | 1995-11-14 | 2001-08-28 | Dupont Pharmaceuticals Company | Macrocyclic compounds as metalloprotease inhibitors |
PT874830E (pt) * | 1995-12-08 | 2003-06-30 | Agouron Pharma | Inibidor de metaloproteinases composicao farmaceutica contendo este inibidor e a utilizacao farmaceutica e metodo util para a sua preparacao |
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
ATE225343T1 (de) * | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
ATE220660T1 (de) | 1996-09-10 | 2002-08-15 | British Biotech Pharm | Cytostatische hydroxamsäurederivate |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
HRP980443A2 (en) | 1997-08-18 | 1999-10-31 | Carl P. Decicco | Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis |
AU2001250571A1 (en) * | 2000-04-28 | 2001-11-12 | P.N. Gerolymatos S.A. | Treatment of pathological conditions influenced by the action of matrix metalloproteinases (mmps) using clioquinol |
AU2003233154A1 (en) | 2002-06-10 | 2003-12-22 | Pfizer Inc. | Metabolites of prinomastat and their sythesis |
OA12937A (en) * | 2002-10-09 | 2006-10-13 | Pfizer Prod Inc | Thiazole compounds for the treatment of neurodegenerative disorders. |
EP1636220A1 (fr) * | 2003-05-12 | 2006-03-22 | Pfizer Products Inc. | Composes isoxazoliques et isothiazoliques destines au traitement de troubles neurodegeneratifs |
WO2004101523A1 (fr) | 2003-05-17 | 2004-11-25 | Korea Research Institute Of Bioscience And Biotechnology | Nouveaux composes 2-oxo-heterocycliques et compositions pharmaceutiques contenant ces composes |
WO2006117660A2 (fr) * | 2005-05-04 | 2006-11-09 | Clio Pharmaceutical Corporation | Methode de traitement du cancer et des maladies coronaire, inflammatoire et maculaire combinant la modulation de proteines dependantes du zinc et/ou du cuivre |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8311286D0 (en) * | 1983-04-26 | 1983-06-02 | Searle & Co | Carboxyalkyl peptide derivatives |
US4568666A (en) * | 1984-10-18 | 1986-02-04 | G. D. Searle & Co. | Carboxylalkyl peptide derivatives |
US4771037A (en) * | 1986-01-21 | 1988-09-13 | Ici Americas Inc. | N-carboxyalkyl compounds |
-
1992
- 1992-05-01 JP JP5500416A patent/JPH06508135A/ja not_active Withdrawn
- 1992-05-01 EP EP92912475A patent/EP0586537A4/en not_active Withdrawn
- 1992-05-01 WO PCT/US1992/003809 patent/WO1992021360A1/fr not_active Application Discontinuation
- 1992-05-01 CA CA002102890A patent/CA2102890A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH06508135A (ja) | 1994-09-14 |
EP0586537A4 (en) | 1997-06-25 |
EP0586537A1 (fr) | 1994-03-16 |
WO1992021360A1 (fr) | 1992-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2102890A1 (fr) | Derives n-carboxyalkylpeptidyles substitues utilises comme agents antidegeneratifs | |
RU2170232C2 (ru) | Амиды фосфиновых кислот и способ предупреждения или лечения заболевания, связанного с нежелательной активностью металлопротеазы | |
US5387610A (en) | Peptide derivatives of collagenase inhibitor | |
FI84472C (fi) | Foerfarande foer framstaellning av kollagenasinhibitorer pao basis av hydroxiaminosyra. | |
KR100352316B1 (ko) | 메탈로프로테아제억제제로서사용되는술포닐아미노치환히드록삼산유도체 | |
US5672583A (en) | Carboxy-peptidyl derivatives as antidegenerative active agents | |
US5679700A (en) | Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents | |
SK63194A3 (en) | Peptide derivatives | |
FR2609289A1 (fr) | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes | |
CZ287780B6 (en) | Peptide derivatives, their use and pharmaceutical preparation in which they are comprised | |
JPH10512241A (ja) | マトリックス・メタロプロテアーゼのヒドロキサム酸含有阻害剤 | |
US5508266A (en) | Gem-disubstituted amino acid derivatives | |
JP3647914B2 (ja) | 環式アミノ酸誘導体 | |
US5506244A (en) | Cyclic amino acid derivatives | |
US5403952A (en) | Substituted cyclic derivatives as novel antidegenerative agents | |
US5629343A (en) | N-(mercaptoacyl) peptidyl derivatives as antidegenerative agents | |
US6090785A (en) | Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents | |
US5932551A (en) | Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents | |
EP0159396B1 (fr) | Dérivés carboxyalkyl peptides | |
WO1995029689A1 (fr) | Derives de n-carboxyalkyle utilises comme agents antidegeneratifs | |
IE65539B1 (en) | Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same | |
CA2196182A1 (fr) | Derives aldehydes utilises comme inhibiteurs de protease d'upsteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |